New Clinical Trial for Treatment of Mesothelioma | About Mesothelioma: Asbestos Exposure and Lung Cancer, Mesothelioma Lawyers & Attorneys Info

TODAYS DATE: Thursday Sep 02, 2010 YOUR ONLINE RESOURCE FOR NEWS ABOUT MESOTHELIOMA

Featured News
Researchers Report Clearer Understanding of H...

The paradox of how asbestos kills cells and yet spurs growth of cancerous tumors has perplexed scientists for decades. A group of scientists led by researchers at the University of Hawaii claim to have…
>READ MORE
International News
Asbestos Fuels Mesot...

With a booming Asian economy, Hong Kong used asbestos extensively in the 1950s and 1960s, particularly in the shipyard and…
>READ MORE

New Clinical Trial for Treatment of Mesothelioma

Friday, March 6th, 2009

Morphotek has announced the beginning of a phase II clinical trial investigating the efficacy of the monoclonal antibody MORAb-009 for the treatment of mesothelioma. The study will evaluate progression-free survival in patients with advanced pleural mesothelioma who are being receiving MORAb-009 in combination with the standard mesothelioma treatment regimen, pemetrexed + cisplatin.
Continue Reading >

Labels: Mesothelioma, Treatments
Link to this article

News Categories

Contributing Author

Wade Rawlins is a former environmental reporter with the Raleigh News & Observer.

Editorial Board

Mike Dayton, Editor
Nancy Meredith, Writer
Aaron Phelps, Writer
Lisa Vaughn, Contributor

Resources For Living

Latest News

News Archives

ARCHIVES:

Copyright About Mesothelioma.net
Website by Consultwebs.com